Safety and immunogenicity of an inactivated thimerosal-free influenza vaccine in infants and children

Autor:	Maryanne V. Skeljo, Gunter Hartel, Russell L. Basser, Jodie McVernon, Jillian Bennet, Terry Nolan, Peter Richmond
Rok vydání:	2009
Předmět:	safety Male Pulmonary and Respiratory Medicine medicine.medical_specialty pediatrics Drug-Related Side Effects and Adverse Reactions Fever Epidemiology Influenza vaccine Immunization Secondary Pain Antibodies Viral Group B Excipients chemistry.chemical_compound Internal medicine Influenza Human medicine Humans Child Adverse effect Reactogenicity Hemagglutination assay business.industry Thimerosal Immunogenicity Australia Public Health Environmental and Occupational Health Infant Original Articles Hemagglutination Inhibition Tests Vaccination Infectious Diseases Vaccines Inactivated chemistry Influenza Vaccines Child Preschool Immunology Female Thiomersal influenza vaccine business
Zdroj:	Influenza and Other Respiratory Viruses
ISSN:	1750-2659 1750-2640
DOI:	10.1111/j.1750-2659.2009.00108.x
Popis:	Objective Few prospective studies of inactivated split virion influenza vaccine have been conducted in infants and children. Our objective was to evaluate the safety, reactogenicity and immunogenicity of a thimerosal-free inactivated influenza vaccine (Fluvax®; CSL Limited, Parkville, Australia) in children aged 6 months to
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57b4392bbe6521c272ce3557089205ff https://doi.org/10.1111/j.1750-2659.2009.00108.x Zobrazit plný text záznamu Plný text ve formátu PDF